You are here

BioMotiv

Bristol-Myers forms fibrotic disease biotech, bags buyout option

Fierce Biotech

Tue, 02/4/20 - 10:08 am

Bristol-Myers Squibb

Anteros Pharmaceuticals

fibrotic disease

Bristol-Myers teams with BioMotiv to build and buy biotechs

Fierce Biotech

Wed, 09/4/19 - 10:25 am

Bristol-Myers Squibb

BioMotiv, Rutgers launch TamRx

BioCentury

Sat, 02/9/19 - 12:28 pm

BioMotiv, Takeda Pharma enter into strategic partnership

PharmaBiz

Sat, 09/27/14 - 09:56 am

Takeda pours $25M into biotech dealmaker BioMotiv

Fierce Biotech

Fri, 09/26/14 - 12:03 pm

BioMotiv garners $46M for early-stage licensing deals, R&D work

Fierce Biotech

Mon, 08/5/13 - 01:46 pm